BioPhysics Pharma
Specialty pharmaceutical company focused on customized medicine. Develops topical, transdermal, transmucosal and oral delivery formulations and supplies compounding bases and USP‑grade active pharmaceutical ingredients (APIs) manufactured/repackaged under cGMP controls for 503A/503B compounding facilities.
Industries
Nr. of Employees
small (1-50)
BioPhysics Pharma
Peabody, Massachusetts, United States, North America
Patents
Products
Compounding bases and certified APIs for 503A/503B facilities
Formulation bases and USP‑certified APIs produced/repackaged under cGMP controls for integration into compounding manufacturing systems used by 503A/503B facilities.
compounding bases
Bases supplied for pharmaceutical compounding to 503a / 503b compounding pharmacists.
active pharmaceutical agents
Active pharmaceutical agents supplied to 503a / 503b compounding pharmacists for customized medicine.
PTM -Technology
A penetrating micro mist oral spray solution designed to enhance penetration of the API through mucosal tissue into systemic circulation, while reducing the amount of API swallowed and passed into the gut. Contains active USP excipients targeting oral mucosal barriers.
Multi-phasic
A topically applied emulsion technology designed to enhance penetration through various skin layers including lipophilic and hydrophilic layers, dense protein layer, and dermis vasculature. Contains active USP grade excipients.
Compounding bases and certified APIs for 503A/503B facilities
Formulation bases and USP‑certified APIs produced/repackaged under cGMP controls for integration into compounding manufacturing systems used by 503A/503B facilities.
compounding bases
Bases supplied for pharmaceutical compounding to 503a / 503b compounding pharmacists.
active pharmaceutical agents
Active pharmaceutical agents supplied to 503a / 503b compounding pharmacists for customized medicine.
PTM -Technology
A penetrating micro mist oral spray solution designed to enhance penetration of the API through mucosal tissue into systemic circulation, while reducing the amount of API swallowed and passed into the gut. Contains active USP excipients targeting oral mucosal barriers.
Multi-phasic
A topically applied emulsion technology designed to enhance penetration through various skin layers including lipophilic and hydrophilic layers, dense protein layer, and dermis vasculature. Contains active USP grade excipients.
Services
Distribution of compounding formulation bases and USP‑grade active pharmaceutical ingredients manufactured/repackaged under cGMP controls and packaged to support dose control in 503A/503B compounding workflows.
Custom development of chemical emulsions and solution bases tailored to specific APIs and intended delivery routes (topical, transdermal, transmucosal), including design considerations for barrier structures and penetration enhancement.
Distribution of compounding formulation bases and USP‑grade active pharmaceutical ingredients manufactured/repackaged under cGMP controls and packaged to support dose control in 503A/503B compounding workflows.
Custom development of chemical emulsions and solution bases tailored to specific APIs and intended delivery routes (topical, transdermal, transmucosal), including design considerations for barrier structures and penetration enhancement.
Expertise Areas
- Topical and transdermal drug delivery
- Transmucosal (oral mucosal) drug delivery
- Formulation development for compounding
- cGMP manufacturing and repackaging for compounding
Key Technologies
- Transdermal delivery systems
- Topical emulsion formulations
- Transmucosal spray (micro‑mist) delivery
- USP‑grade excipients
News & Updates
Placeholder news page indicating forthcoming news and media updates.
Placeholder news page indicating forthcoming news and media updates.